Search results for "Keeping tabs"
Spotlight on diabetes prevention
Recent studies looked at vitamin D supplementation, peer mentoring, and physician referrals to diabetes prevention programs among patients with prediabetes.
https://diabetes.acponline.org/archives/2019/06/14/5.htm
14 Jun 2019
Spotlight on diabetes drug class comparisons
A large trial compared insulin, a sulfonylurea, a glucagon-like peptide-1 (GLP-1) receptor agonist, and a dipeptidyl peptidase-4 inhibitor as second-line therapy, while a modeling study considered GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors as first-line agents.
https://diabetes.acponline.org/archives/2022/10/14/5.htm
14 Oct 2022
Spotlight on pregnancy in women with diabetes
Recent studies looked at aspects of pregnancy in women with pre-existing type 1 or 2 diabetes, including rates of adverse outcomes, useful biomarkers, and typical dietary patterns.
https://diabetes.acponline.org/archives/2021/02/12/5.htm
12 Feb 2021
Spotlight on young-onset type 2 diabetes
Some recent studies investigated cardiovascular disease, mortality risk, kidney disease, and the evidence base among patients who develop type 2 diabetes before age 40 or 50 years.
https://diabetes.acponline.org/archives/2020/07/10/5.htm
10 Jul 2020
Spotlight on gestational diabetes and CVD
Having gestational diabetes, or even elevated glucose levels during pregnancy, may be associated with increased risk of metabolic syndrome and cardiovascular disease (CVD) later, according to three recent studies.
https://diabetes.acponline.org/archives/2019/04/05/5.htm
5 Apr 2019
Spotlight on GLP-1 receptor agonists and the lungs
The theory that glucagon-like peptide-1 (GLP-1) receptor agonists may have beneficial effects on the lungs gained support from recent analyses of patients with asthma, chronic lower respiratory diseases, and all types of respiratory diseases.
https://diabetes.acponline.org/archives/2021/05/14/5.htm
14 May 2021
Spotlight on weekly insulins
Pharmaceutical manufacturers recently published studies on investigational basal insulin formulations that could be taken once a week by patients with type 1 or type 2 diabetes.
https://diabetes.acponline.org/archives/2023/05/12/5.htm
12 May 2023
Spotlight on heart failure and diabetes
A new study validated a score for predicting risk of heart failure in patients with type 2 diabetes, while another looked at historical trends in heart failure hospitalizations in U.S. diabetes patients.
https://diabetes.acponline.org/archives/2020/12/11/5.htm
11 Dec 2020
Spotlight on efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists
One recent study compared sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to each other, a meta-analysis tried to quantify their benefits compared to placebo, and a third study looked at their effects relative to insulin.
https://diabetes.acponline.org/archives/2022/05/13/5.htm
13 May 2022
Spotlight on diabetes after COVID-19
A cohort study in U.S. veterans and a retrospective analysis in Germany found higher risk for incident diabetes in patients who had had COVID-19.
https://diabetes.acponline.org/archives/2022/04/08/5.htm
8 Apr 2022